Table 1.
Serum adipocytokines and TBARS Mice were subjected to sham or OVX surgeries and received the daily drug treatments for 8 weeks. Values represent means±S.E (n=10).
| Treatment group |
P | |||||||
|---|---|---|---|---|---|---|---|---|
| Sham | OVX |
|||||||
| Control | E2 | CE | BZA | E2+BZA | CE+BZA | |||
| Leptin, ng/mL | 18.35±2.05b | 31.13±2.22a | 5.69±0.65c,d | 2.09±0.66d | 9.47±1.40c | 1.96±0.61d | 1.43±0.22d | <0.0001 |
| Adiponectin, μg/mL | 14.99±0.23a | 16.75±1.25a | 10.40±0.36c | 11.68±0.29b,c | 14.05±0.53a,b | 9.54±0.72c | 12.02±0.49b,c | <0.0001 |
| Leptin/adiponectin | 1.23±0.14b | 1.93±0.18a | 0.55±0.06c,d | 0.18±0.06d | 0.65±0.09c | 0.19±0.05d | 0.12±0.02d | <0.0001 |
| RBP4, μg/mL | 4.27±0.22a,b | 4.59±0.12a | 3.41±0.16c,d | 3.94±0.26a,b,c | 3.66±0.15b,c | 2.85±0.16d | 3.54±0.13b,c,d | <0.0001 |
| Lipocalin2, ng/mL | 116.4±13.8b,c | 112.2±22.0b,c | 284.9±65.1a,b | 89.8±11.5c | 70.7±9.6c | 348.4±85.0a | 80.3±14.8c | <0.0001 |
| TBARS, nmol MDA/mL | 46.4±0.8a,b | 53.6±3.7a | 16.2±1.2c | 37.5±2.1b | 47.7±3.0a | 19.4±1.5c | 22.8±1.0c | <0.0001 |
a–dMeans with different superscripts within the same row are significantly different (P<0.05).